Hepatocellular Carcinoma Surveillance among Patients with Cirrhosis in a Population-based Integrated Health Care Delivery System

Amit G. Singal, Jasmin Tiro, Xilong Li, Beverley Adams-Huet, Jessica Chubak

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


Purpose: Fewer than 1 in 5 patients with cirrhosis receive hepatocellular carcinoma (HCC) surveillance; however, most studies were performed in select patient populations, which may not be informative of practice patterns in population-based community practices. Further, few reported guideline-concordant consistent surveillance rates. Goals: Characterize guideline-concordant HCC surveillance rates and patient-level factors associated with surveillance among a population-based cohort of patients with cirrhosis. Study: We retrospectively characterized HCC surveillance among cirrhosis patients followed between January 2010 and December 2012 at an integrated health care delivery system in Washington state. Consistent surveillance was defined as an ultrasound every 6 months, and inconsistent surveillance was defined as ≥1 ultrasound during the 2-year follow-up period. Univariate and multivariate analyses were conducted to identify correlates of HCC surveillance receipt. Results: Of 1137 patients with cirrhosis, 22 (2%) underwent consistent surveillance, 371 (33%) had inconsistent surveillance, and 744 (65%) received no surveillance during follow-up. Correlates of HCC surveillance receipt in multivariate analysis included Gastroenterology/Hepatology subspecialty care [odds ratio (OR), 1.88; 95% confidence interval (CI), 1.44-2.46], Child Pugh B/C cirrhosis (OR, 1.61; 95% CI, 1.07-2.43), elevated aspartate aminotransferase (OR, 1.63; 95% CI, 1.13-2.35), and etiology of liver disease. Compared with hepatitis C-infected patients, patients with hepatitis B infection were more likely to undergo surveillance (OR, 2.72; 95% CI, 1.28-5.81), whereas patients with alcohol-related cirrhosis (OR, 0.63; 95% CI, 0.42-0.93) and nonalcoholic steatohepatitis (OR, 0.39; 95% CI, 0.28-0.56) were less likely to undergo surveillance. Conclusions: Although one third of patients undergo inconsistent HCC surveillance, <2% of patients receive guideline-concordant biannual HCC surveillance.

Original languageEnglish (US)
Pages (from-to)650-655
Number of pages6
JournalJournal of Clinical Gastroenterology
Issue number7
StatePublished - 2017


  • cirrhosis
  • early detection
  • liver cancer
  • screening
  • ultrasound

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Hepatocellular Carcinoma Surveillance among Patients with Cirrhosis in a Population-based Integrated Health Care Delivery System'. Together they form a unique fingerprint.

Cite this